SloMo2: A process evaluation, effectiveness and cost-effectiveness study of a digitally supported therapy for psychosis in routine care

Our vision is to spread and sustain SlowMo therapy in mental health services, transforming outcomes for people with paranoia worldwide. The funding will lead to the following achievements: 1. Software code for SlowMo2 which has been co-designed with people with lived experience to support adoption by a) optimising impact on valued outcomes, b) ensuring suitability for widespread adoption across the psychological practitioner workforce and c) maintain strong user experience for a diverse range of people to support engagement. 2. Development of an e-learning package to automate workforce training. This will incorporate core training for established clinicians and an extended version specifically targeting the international need to expand low intensity psychological practitioner roles. 3. Endorsement of SlowMo’s value proposition by adopters, implementation partners and regulatory bodies, having further demonstrated effectiveness and cost effectiveness in routine care. 4. A commercialisation strategy and NHS Global Digital Exemplar Blueprint to support spread and sustainment of SlowMo, assisted by organisational support from the IoPPN’s digital therapeutics strategy and the King’s20 Accelerator. 5. Expansion of our lived experience community, collaboratively harnessing their expertise to expand SlowMo’s value proposition, including peer-led recovery college courses and product development of novel therapeutic targets.